Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Thescientificworldjournal|September 6, 2005
Angiotensin II and renal tubular ion transportPatricia Valles, Jan Wysocki, Daniel BatlleClinical Science (London, England : 1979)|November 2, 2020
ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discoveryEnrique Lores, Jan Wysocki, Daniel BatlleHypertension (Dallas, Tex. : 1979)|December 3, 2024
ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023Daniel Batlle, Luise Hassler, Jan WysockiBiomolecules|December 22, 2019
Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin SystemJan Wysocki, Arndt Schulze, Daniel BatlleClinical Science (London, England : 1979)|March 14, 2020
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?Daniel Batlle, Jan Wysocki, Karla SatchellAmerican Journal of Hypertension|May 14, 2015
Plasma and Kidney Angiotensin Peptides: Importance of the Aminopeptidase A/Angiotensin III AxisJan Wysocki, Minghao Ye, Daniel BatlleCurrent Opinion in Nephrology and Hypertension|April 15, 2008
New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathyDaniel Batlle, María José Soler, Jan WysockiNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 20, 2013
ACE2 alterations in kidney diseaseMaría José Soler, Jan Wysocki, Daniel BatlleHypertension (Dallas, Tex. : 1979)|August 28, 2020
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic ImplicationsAnne M Davidson, Jan Wysocki, Daniel BatlleExperimental Physiology|January 29, 2008
Angiotensin-converting enzyme 2 and the kidneyMaria Jose Soler, Jan Wysocki, Daniel BatllePageof 13